Invested with the capacity to reinstate physiological order, medicines are at the
centre of contemporary health care. Their purpose and efficacy are generally seen as
predictable and concrete: disease = therapy = outcome. These culturally specific
understandings shape the practices and meanings of taking medicines. This article,
however, queries what actually takes place when human bodies and medical drugs
converge. Is it a solely therapeutic affair, a restoration of bodily normality, or
one of multiple transformations? The ambivalent meaning of the original Greek word
for drug, pharmakon, intimates the potential of medicines to act as
‘remedy’ as well as ‘poison’. Using
pharmakon as a conceptual tool, the article explores the complex, and often
paradoxical corporeal effects of HIV combination therapy, with particular focus on
lipodystrophy, a peculiar change in people‘s body shape. This unintended
and frequently distressing iatro-genic phenomenon challenges common notions of
therapeutic efficacy and causality and foregrounds the productive dimension of
medical drugs - their capacity to reconfigure bodies, diseases and identities in
multiple, unpredictable ways.
Appadurai, A.
(1986) ‘Commodities and the Politics of
Value’, in
A. Appadurai
(ed.) The Social Life of Things, pp. 3-63.
Cambridge: Cambridge University Press
.
2.
Ariss, R.
(1997) Against Death: The Practice of Living with AIDS.
Amsterdam: Gordon and Breach
.
3.
Bass, E.
(2001) ‘Drug Toxicities Multiply and the Mystery
Grows’,
American Foundation for AIDS Research
, http://ww2.aegis.org/pubs/amfar/2001/am010303.html
4.
Broadhead, R.S.
and
N.J. Facchinetti
(1985)
‘Drug Iatrogenesis and Clinical Pharmacy: The Mutual Fate of a
Social Problem and a Professional Movement’
, Social Problems32(5):
425-436
.
5.
Carpenter, C.J.
,
M.A. Fischl
,
S.M. Hammer
,
M.S. Hirsch
,
D.M. Jacobsen
,
D.A. Katzenstein
,
J.S. Montaner
,
D.D. Richman
,
M.S. Saag
,
R.T. Schooley
,
M.A. Thompson
,
S. Vella
,
P.G. Yeni
and
P.A. Volberdinger
(1997)
‘Antiretroviral Therapy for HIV Infection in 1997: Updated
Recommendations of the International AIDS Society USA Panel’
, Journal of the American Medical Association276(2):
146-154
.
6.
Carr, A.
(2003)
‘HIV Lipodystrophy: Risk Factors, Pathogenesis, Diagnosis and Management’
, AIDS17 (Suppl 1):
S141-S148
.
7.
Carr, A.
and
D. Cooper
(2000)
‘Adverse Effects of Antiretroviral Therapy’
, The Lancet356(9239):
1423-1430
.
8.
Carr, A.
,
S. Emery
,
M. Law
,
R. Puls
,
J.D. Lundgren
and
W.G. Powderly
(2003)
‘An Objective Case Definition of Lipodystrophy in HIV-infected
Adults: A Case-control Study’
, The Lancet361 (9359):
726-735
.
9.
Carr, A.
,
K. Samaras
,
S. Burton
,
M. Law
,
J. Freund
,
D.J. Chisholm
and
D.A. Cooper
(1998)
‘A Syndrome of Peripheral Lipodystrophy, Hyperlipidaemia and
Insulin Resistance in Patients Receiving HIV Protease Inhibitors’
, AIDS12(7):
F51-F58
10.
Carr, A.
,
K. Samaras
,
A. Thorisdottir
,
G.R. Kaufmann
,
D.J. Chisholm
and
D.A. Cooper
(1999)
‘Diagnosis, Prediction, and Natural Course of HIV-1
Protease-inhibitor-associated Lipodystrophy, Hyper-lipidaemia and Diabetes
Mellitus: A Cohort Study’
, The Lancet353(9170):
2093-2099
.
11.
Carter, V.M.
,
J.F. Hoy
,
M. Bailey
,
P.G. Colman
,
I. Nyulasi
and
A.M. Mijch
(2001)
‘The Prevalence of Lipodystrophy in an Ambulant HIV-infected
Population: It all Depends on the Definition’
, HIV Medicine2(3):
174-180
.
12.
Cohen, D.
,
M. McCubbin
,
J. Collin
and
G. Pérodeau
(2001)
‘Medications as Social Phenomena’
, Health: An Interdisciplinary Journal for the Social Study of
Health, Illness and Medicine5(4):
441-469
.
13.
Collins, E.
,
C. Wagner
and
S. Walmsley
(2000)
‘Psychosocial Impact of the Lipodystrophy Syndrome in HIV Infection’
, The AIDS ReaderSeptember:
546-550
.
14.
Crawford, R.
(1994)
‘The Boundaries of the Self and the Unhealthy Other: Reflections
on Health, Culture and AIDS’
, Social Science and Medicine38(10):
1347-1365
.
15.
Davis, P.
(1996) ‘Introduction: Medicines in a Postmodern
World’, in
P. Davis
(ed.) Contested Ground: Public Purpose and Private Interest in the
Regulation of Prescription Drugs, pp. 3-8.
New York and Oxford: Oxford University Press
.
16.
Day, M.
(2000)
‘No More Cocktails’
, New Scientist168(2269):
7-9
.
17.
Delaney, M.
(2002)
‘Accelerated Approval: Where Are We Now?’
, RITA: Research Initiative/Treatment Action!8(1):
18-22
.
Houston, TX: Centre for AIDS
.
18.
Deleuze, G.
and
F. Guattari
(1987) A Thousand Plateaus.
Minneapolis: University of Minnesota Press
.
19.
Derrida, J.
(2000[1981]) ‘Plato’s
Pharmacy’, in Dissemination, pp.
61-171.
London: The Athlone Press
.
20.
Desjarlais, R.R.
(1992) Body and Emotion: The Aesthetic of Illness and Healing
in the Nepal Himalayas.
Philadelphia: University of Pennsylvania Press
.
21.
Dore, G.
,
A. Grulich
,
M. Kidd
,
J. Hoy
,
R. McCoy
,
A. Mijch
and
S. Strasser
(eds) (2001) HIV/Viral Hepatitis: A Guide to Primary
Care.
Sydney: Australasian Society for HIV Medicine (ASHM)
.
22.
Ellard, J.
(2002)
‘Negotiating Sex, Intimacy and Risk in Sero-discordant Regular Relationships’
. Paper presented at Sero-discordant Relationships Forum,
NSW Department of Health, Sydney, September.
23.
Etkin, N.L.
(1992)
‘“Side Effects”: Cultural Constructions and
Reinterpretations of Western Pharmaceuticals’
, Medical Anthropology Quarterly6(2):
99-113
.
24.
Fee, E.
and
D. Fox
(1992) AIDS: The Making of a Chronic Disease.
Berkeley: University of California Press
.
25.
Foucault, M.
(1975[1963]) Birth of the Clinic: An Archaeology of Medical
Perception.
New York: Vintage
.
26.
Frank, A.W.
(1995) The Wounded Storyteller: Body, Illness and
Ethics.
Chicago, IL and London: University of Chicago Press
.
27.
Gilman, S.
(1988) Disease and Representation: Images of Illness from
Madness to AIDS.
Ithaca, NY and London: Cornell University Press
.
28.
Gilman, S.
(1995) Health and Illness: Images of Difference.
London: Reaktion Books
.
29.
Grosz, E.
(1994) Volatile Bodies: Towards a Corporeal Feminism.
Sydney: Allen and Unwin
.
30.
Gulick, R.
,
J. Mellors
,
D. Havliret al.
(1998)
‘Simultaneous vs Sequential Initiation of Therapy with Indinavir,
Zidovudine, and Lamivudine for HIV-1 Infection: 100-week Follow Up’
, Journal of the American Medical Association280(1):
35-41
.
31.
Haraway, D.
(1989)
‘The Biopolitics of Postmodern Bodies: Determinations of Self in
Immune System Discourse’
, Differences1(1):
3-43
.
32.
Helman, C.
(1990) Culture, Health and Illness.
London and Boston, MA: Wright
.
33.
Ho, D.D.
(1995)
‘Time to Hit HIV, Early and Hard’
, The New England Journal of Medicine333(7):
450-451
.
34.
Hurley, M.
(2001)
‘Rethinking the Clinic: Doctors, People Living with HIV and AIDS
and Cultures of Care’
. Paper presented at 13th Annual Conference of Australasian
Society for HIV Medicine, Melbourne.
35.
Illich, I.
(1976) Medical Nemesis: The Expropriation of Health.
New York: Pantheon
.
36.
Kitzinger, J.
(1995) ‘The Face of AIDS’, in
Markova, I.
and
Farr, R.M.
(eds) Representations of Health, Illness and Handicap, pp.
49-66.
Singapore: Harwood Academic Publishers
.
37.
Kleinman, A.
(1988) The Illness Narratives: Suffering, Healing, and the
Human Condition.
New York: Basic Books
.
38.
Kleinman, A.
(1995) Writing at the Margin: Discourse between Anthropology
and Medicine.
Berkeley: University of California Press
.
39.
Lauritsen, J.
(1990) Poison by Prescription: The AZT Story.
New York: Asklepios
.
40.
Leder, D.
(1990) The Absent Body.
Chicago, IL: University of Chicago Press
.
41.
Machon, K.
(1999)
‘Cause and Effect’
, HIV Herald8(5):
3-4
.
42.
Machon, K.
and
C. Batrouney
(1999)
‘An A-Z of Side Effects’
, HIV Herald8(5):
9-18
.
43.
Martin, E.
(1992)
‘The End of the Body?’
, American Ethnologist19(1):
121-140
.
44.
Martin, E.
(1994) Flexible Bodies: The Role of Immunity in American
Culture from the Days of Polio to the Age of AIDS.
Boston, MA: Beacon Press
.
45.
Mascolini, M.
(1999)
‘Crossing the Waters to the Post-HAART Era’
, Journal of the International Association of Physicians in AIDS CareDecember:
13-51
.
46.
Merleau-Ponty, M.
(1962) Phenomenology of Perception.
London: Routledge and Kegan Paul
.
47.
Miller, J.
,
A. Carr
,
S. Emery
,
M. Law
,
S. Mallal
,
D. Baker
,
D. Smith
,
J. Kaldor
and
D.A. Cooper
(2003)
‘HIV Lipodystrophy: Prevalence, Severity and Correlates of Risk
in Australia’
, HIV Medicine4(3):
293-301
.
48.
Montagne, M.
(1996) ‘The Pharmakon Phenomenon: Cultural
Conceptions of Drugs and Drug Use’, in
P. Davis
(ed.) Contested Ground: Public Purpose and Private Interest in the
Regulation of Prescription Drugs, pp. 11-25.
New York and Oxford: Oxford University Press
.
49.
Nass, H.
(2003) ‘Metabolic Complications: A Look at the IAS
Guidelines’,
AIDS Community Research Initiative of America (ACRIA)
, http://ww2.aegis.org/pubs/cria/2003/CR030406.html
50.
Nichter, M.
and
N. Vuckovic
(1994)
‘Agenda for an Anthropology of Pharmaceutical Practice’
, Social Science and Medicine39(11):
1509-1525
.
51.
Obeyesekere, G.
(1980) Rationality, Theory, and Experimentation in Ayurvedic
Medicine.
Tokyo: The United Nations University
.
52.
Ohnuki-Tierney, E.
(1981) Illness and Healing Among the Sakhalin Ainu: A
Symbolic Interpretation.
Cambridge: Cambridge University Press
.
53.
Persson, A.
,
K. Race
and
E. Wakeford
(2003)
‘HIV Health in Context: Negotiating Medical Technology and Lived Experience’
, Health: An Interdisciplinary Journal for the Social Study of
Health, Illness and Medicine7(4):
397-415
.
54.
Power, R.
,
H.L. Tate
,
S.M. McGill
and
C. Taylor
(2003)
‘A Qualitative Study of the Psychosocial Implications of
Lipodystrophy Syndrome on HIV Positive Individuals’
, Sexually Transmitted Infections79(2):
137-141
.
55.
Race, K.
(2001a)
‘The Undetectable Crisis: Changing Technologies of Risk’
, Sexualities4(2):
167-189
.
56.
Race, K.
(2001b) ‘Incorporating Clinical Authority: A New
Test for People with HIV’, in
N. Watson
and
S. Cunningham-Burley
(eds) Reframing the Body, pp. 81-95.
Hampshire and New York: Palgrave
.
57.
Rofes, E.
(1998) Dry Bones Breathe: Gay Men Creating Post-AIDS
Identities and Cultures.
New York and London: Harrington Park Press
.
58.
Rosello, M.
(1998)
‘Pictures of a Virus: Ideological Choices and the Representation
of HIV’
, French Cultural Studies9(27):
337-349
.
59.
Siegel, K.
and
H-M. Lekas
(2002)
‘AIDS as a Chronic Illness: Psychosocial Implications’
, AIDS16 (suppl 4):
S69-S76
.
60.
Silverman, M.
and
P.R. Lee
(1974) Pills, Profits, and Politics.
Berkeley: University of California
.
61.
Sontag, S.
(1990) AIDS and its Metaphors.
New York: Doubleday
.
62.
Stewart, G.
(ed.) (1997) Managing HIV.
Sydney: Australasian Medical Publishing Company Limited
.
63.
Taylor, C.C.
(1988)
‘The Concept of Flow in Rwandan Popular Medicine’
, Social Science and Medicine27(12):
1343-1348
.
64.
Toombs, S.K.
(1988)
‘Illness and the Paradigm of Lived Body’
, Theoretical Medicine9(2):
201-226
.
65.
Treichler, P.
(1991) ‘AIDS, Homophobia, and Biomedical
Discourse: An Epidemic of Signification’, in
D. Crimp
(ed.) AIDS: Cultural Analysis, Cultural Activism, pp.
31-70.
Cambridge, MA and London: MIT Press
.
66.
Van der Geest, S.
and
S.R. Whyte
(eds) (1988) The Context of Medicines in Developing
Countries.
Dordrecht: Kluwer Academic Publishers
.
67.
Van der Geest, S.
and
S.R. Whyte
(1989)
‘The Charm of Medicines: Metaphors and Metonyms’
, Medical Anthropology Quarterly3(4):
345-367
.
68.
Van der Geest, S.
,
S.R. Whyte
and
A. Hardon
(1996)
‘The Anthropology of Pharmaceuticals: A Biographical Approach’
, Annual Review of Anthropology25(1):
153-178
.
69.
Voelker, R.
(1996)
‘Can Researchers Use New Drugs to Push HIV Envelope to Extinction?’
, Journal of the American Medical Association276(6):
435-437
.
70.
Volberding, P.A.
and
S. Deeks
(1998)
‘Antiretroviral Therapy for HIV Infection: Promises and Problems’
, Journal of the American Medical Association279(17):
1343-1344
.
71.
Waldby, C.
(1999)
‘IatroGenesis: The Visible Human Project and the Reproduction of Life’
, Australian Feminist Studies14(29):
77-90
.
72.
Willems, D.
(1998) ‘Inhaling Drugs and Making Worlds: A
Proliferation of Lungs and Asthmas’, in
M. Berg
and
A. Mol
(eds) Differences in Medicine: Unravelling Practices, Techniques, and
Bodies, pp. 105-118.
Durham, NC and London: Duke University Press
.
73.
Williams, S.
and
G. Bendelow
(2000)
‘“Recalcitrant Bodies”? Children, Cancer and
the Transgressions of Corporeal Boundaries’
, Health: An Interdisciplinary Journal for the Social Study of
Health, Illness and Medicine4(1):
51-71
.
74.
Williams, S.
and
M. Calnan
(1996)
‘The “Limits” of Medicalization? Modern
Medicine and the Lay Populace in “Late” Modernity’
, Social Science and Medicine42(12):
1609-1620
.
